Fortress Biotech
FBIO
81 hedge funds and large institutions have $158M invested in Fortress Biotech in 2013 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 10 reducing their positions, and 6 closing their positions.
290% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 10
264% more call options, than puts
Call options by funds: $20.3M | Put options by funds: $5.59M
217% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 6
19% more funds holding
Funds holding: 68 → 81 (+13)
12% more capital invested
Capital invested by funds: $141M → $158M (+$17.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.9M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$11.3M |
| 3 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
+$6.33M |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$4.29M |
| 5 |
CIP
Chartwell Investment Partners
Berywn,
Pennsylvania
|
+$4.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.74M |
| 2 |
SCM
Suffolk Capital Management
New York
|
-$3.21M |
| 3 |
SC
Sophrosyne Capital
New York
|
-$1.59M |
| 4 |
PC
PointState Capital
New York
|
-$1.32M |
| 5 |
MCM
Montibus Capital Management
Portland,
Oregon
|
-$329K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EWM
76
Edge Wealth Management
New York
| $11K | -$13.1K | -107 | -52% |
|
|
PCM
77
Prelude Capital Management
New York
| $9K | +$10.4K | +85 | New |
|
78
BlackRock
New York
| $6K | +$1.72K | +14 | +33% |
|
|
WA
79
WFG Advisors
Dallas,
Texas
| $2K | – | – | – |
|
|
RFC
80
Russell Frank Company
Seattle,
Washington
| $1K | – | – | – |
|
81
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $132 | -$17.2K | -140 | -10% |
|
|
DCM
82
Driehaus Capital Management
Chicago,
Illinois
| – | -$3.74M | -28,962 | Closed |
|
|
SCM
83
Suffolk Capital Management
New York
| – | -$3.21M | -24,907 | Closed |
|
|
SC
84
Sophrosyne Capital
New York
| – | -$1.59M | -12,300 | Closed |
|
85
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$294K | -2,398 | Closed |
|
86
Two Sigma Investments
New York
| – | -$141K | -1,094 | Closed |
|
87
Jane Street
New York
| – | -$95K | -739 | Closed |
|
FBIO Hedge Fund Activity: Q3 2013 in Review
81 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2013, worth a combined $158M — up 12% from $141M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new FBIO positions and 6 closed out — a net gain of 13 holders — while 39 added to existing stakes and 10 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $11.9M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $3.74M sold.
- 81 institutional investors held Fortress Biotech (FBIO) as of Q3 2013, up from 68 in Q2 2013.
- Funds reported $158M of Fortress Biotech stock for Q3 2013, up 12% quarter-over-quarter.
- 19 funds opened new Fortress Biotech positions in Q3 2013 and 6 closed out, a net change of +13 holders.
- The largest Fortress Biotech buyer in Q3 2013 was Fidelity Investments, an estimated $11.9M added.
- The largest Fortress Biotech seller in Q3 2013 was Driehaus Capital Management, an estimated $3.74M sold.
Based on aggregated 13F filings for Q3 2013.